" "
 
Introducing
  • Use is clinically shown to reduce A1C and increase time-in-range (1,2)

  • Easy to teach, learn, and use (1,3)

  • Preferred by people with diabetes and healthcare professionals (1)

MEALTIME INSULIN IS 
ALWAYS WITHIN REACH

2-Button Safety Mechanism

Ensures that dosing occurs only when intended—designed to prevent accidental dosing (5)

Adhesive Patch

Designed to keep the Patch on skin for up to 3 days

Buttons Lock To Notify

Stay in “squeezed” position when Patch is empty or cannula is occluded (5)

Water-Resistant

To a depth of 1 meter for up to 30 minutes

Tactile & Audible Feedback

Indicates 2-unit delivery (5)

Use Of CeQur Simplicity Is
Clinically Shown To Improve Glycemic Control (1,2)
Time Chart Baseline
Time Chart Week-24

After 24 Weeks With CeQur Simplicity, users increased time in range (TIR) by 50%. (2)

The International Consensus on Time In Range defines clinical target for TIR ≥ 70%, which is evidenced to be equivalent to an A1C ≤ 7%. (6)

CeQur Simplicity holds up to 200 units of rapid-acting insulin administered in 2-unit increments.

Simplicity Features

*Labeled for use with Humalog® U-100 and NovoLog® U-100. Insulin sold separately.

With Use Of CeQur Simplicity
A1C Target Goals Were Achieved (1)
A1C Reduction Chart

Clinical Outcome Study Findings (1). Mean A1C was reduced to target goal by Week 24.

Results were comparable to pens. Consistent A1C <7% supports HEDIS Comprehensive Diabetes Care measure.

The convenient, discreet, 3-day, wearable insulin Patch for injection-free dosing

MEALTIME INSULIN IS ALWAYS WITHIN REACH

Couple Cequr Header

References:

  1. Bergenstal R, Peyrot M, Dreon D, Aroda V, Bailey T, Brazg R, Frias J, Johnson M, Klonoff D, Kruger D, Ramtoola S, Rosenstock J, Serusclat P, Weinstock R, Naik R, Shearer D, Zraick V, Levy B on behalf of the Calibra Study Group. 2019. Implementation of Basal-Bolus Therapy in Type 2 Diabetes: A Randomized Controlled Trial Comparing Bolus Insulin Delivery Using an Insulin Patch with and Insulin Pen. Diabetes Technology and Therapeutics 21 (5):1-13.

  2. Johnson ML, Dreon DM, Levy BL, Richter S, Mullen D, Bergenstal R. 2018. Comparing Patch vs. Pen Bolus Insulin Delivery in Type 2 Diabetes Using Continuous Glucose Monitoring Metrics and Profiles. Diabetes 2018 Jul; 67(Supplement 1)

  3. Zraick V, Dreon D, Nalk R, Shearer D, Crawford S, Bradford J, Levy B. 2016. Patient User Experience Evaluation of Bolus Patch Insulin Delivery System. Poster presented at the American Diabetes Association’s 76th Scientific Sessions. Abstract 995-P. New Orleans, LA, USA.

  4. Peyrot M, Dreon D, Zraick V, Cross B, Tan MH. 2018. Patient Perceptions and Preferences for a Mealtime Insulin Delivery Patch. Diabetes Therapy. 9(1):297–307.

  5. Dreon D, Hannon T, Cross B, Carter B, Mercer N, Nguyen J, Tran A , Melendez P, Morales N, Nelson J, Tan M. 2018. Laboratory and Benchtop Performance of a Mealtime Insulin-Delivery System. Journal of Diabetes Science and Technology. 12(4):817-827.

  6. Battelino T, Danne T, Bergenstal R, Amiel S, Beck R, Biester T, Bosi E, Buckingham B, Cefalu W, Close K, Cobelli C, Dassau E, DeVries J, Donaghue K, Dovc K, Doyle F, Garg S, Grunberger G, Heller S, Heinemann L, Hirsch I, Hovorka R, Jia W, Kordonouri O, Kovatchev B, Kowalski A, Laffel L, LevineB, Mayorov A, Mathieu C, Murphy H, Nimri R, Nørgaard K, Parkin C, Renard E, Rodbard D, Saboo B, Schatz D, Stoner K, Urakami T, Weinzimer S, Phillip M. 2019. Clinical Targets for Continuous Glucose Monitoring Data Interpretation: Recommendations From the International Consensus on Time in Range. Diabetes Care Aug 2019, 42 (8) 1593-1603

  7. Bohannon N, Bergenstal R, Cuddihy R, Kruger D, List S, Massaro E, Molich M, Raskin P, Remtema H, Strowig S, Whitehouse F, Brunelle R, Dreon D, Tan M. 2011. Comparison of a Novel Insulin Bolus-Patch with Pen/Syringe Injection to Deliver Mealtime Insulin for Efficacy, Preference, and Quality of Life in Adults with Diabetes: A Randomized, Crossover, Multicenter Study. Diabetes Technology & Therapeutics. 13(10):1031-1037.

Humalog® is a registered trademark of Eli Lilly and Company. NovoLog® is a registered trademark of Novo Nordisk A/S.

CeQur Simplicity Features

Simplify Mealtimes 
With A Click

CeQur Simplicity™ removes known barriers to mealtime dosing (4), such as inconvenience, embarrassment, and injection pain.

CeQur Simplicity Is 
Designed For Safety

Introducing
  • Use is clinically shown to reduce A1C and increase time-in-range (1,2)

  • Easy to teach, learn, and use (1,3)

  • Preferred by people with diabetes and healthcare professionals (1)

MEALTIME INSULIN IS 
ALWAYS WITHIN REACH

3-day Insulin Patch

2-Button Safety Mechanism

Ensures that dosing occurs only when intended—designed to prevent accidental dosing (5)

Adhesive Patch

Designed to keep the Patch on skin for up to 3 days

Buttons Lock To Notify

Stay in “squeezed” position when Patch is empty or cannula is occluded (5)

Water-Resistant

To a depth of 1 meter for up to 30 minutes

Tactile & Audible Feedback

Indicates 2-unit delivery (5)

2 Button Mechanism Patch
CeQur Simplicity Is 
Designed For Safety
Happy User Mid-Section

Users Prefer CeQur Simplicity

88%

said they follow their insulin regimen better with CeQur Simplicity (3)

86%

were satisfied with CeQur Simplicity (3)

76%

asked to be switched from pen or syringe (7)

72%

preferred CeQur Simplicity over pens (1)

CeQur Simplicity Encourages Adherence

Many people using CeQur Simplicity said they dosed in instances where they probably wouldn’t have dosed with a pen or syringe and stated they are likely to dose more often across meals, snacks, and correction boluses. (3)

Users Prefer CeQur Simplicity

said they follow their insulin regimen better with CeQur Simplicity (3)

were satisfied with CeQur Simplicity (3)

asked to be switched from pen or syringe (7)

preferred CeQur Simplicity over pens (1)

CeQur Simplicity Encourages Adherence

Many people using CeQur Simplicity said they dosed in instances where they probably wouldn’t have dosed with a pen or syringe and stated they are likely to dose more often across meals, snacks, and correction boluses. (3)

Get To Know
CeQur Simplicity Users
Learn how CeQur Simplicity works for people with diabetes. Hear their stories and their personal experiences. 
Convient Patch

Convenient

  • Fits into the lives of people requiring mealtime insulin dosing

  • Wearable while showering, sleeping, exercising, and swimming (5)

  • Easy to use (3)

Discreet patch

Discreet

  • Worn and dosed under clothing

  • Compact design

  • Small (65x36 mm), lightweight (10 gm), and thin (<4 quarters thick)

  • Less embarrassment while dosing can lead to better adherence (1)

Injection Free Patch

Injection-Free Dosing

  • Fewer injections

    • 1 Patch replaces 9 mealtime injections, for ~90 fewer injections per month

  • Less pain

    • 90% of users reported mealtime insulin painless with CeQur Simplicity (1)

Hear What Dr. Levy

Thinks About CeQur Simplicity

“As a diabetologist I understand the challenges that patients with diabetes have who require doses several times a day, especially for meals. Patients have busy lives. They’re out socializing over dinner with family or friends, or at an important work meeting, or in school. They do need their insulin before eating but either choose not to take it or forget to take it because of that social setting. So, I’ve seen firsthand in the CeQur Simplicity clinical study that the Simplicity patch allows patients a simple, discreet, and convenient way not to miss their mealtime insulin, but rather, to always take their insulin. The result is an improvement in overall diabetes control and a happier patient. “
-Brian Levy, MD Endocrinologist 

Sign Up To Stay Up to Date

Get product news, offers, and more.

Thanks for submitting!

We respect the importance of your privacy and understand your health is a very personal and sensitive subject. CeQur Simplicity wants you to understand how it will use the information provided by you on this registration page. By clicking the “Submit” button above, you are indicating that CeQur Simplicity or its partners may use your information for program improvements, quality monitoring, data and analytics for commercial purposes, and future marketing communications. You also understand that you may opt out from receiving any future communications from CeQur Simplicity or its partners by clicking the “unsubscribe” link within any email you receive, or by calling 1-888-552-3787.
 
To better understand how CeQur Simplicity values your privacy, please see our Privacy Policy.  

By using this website, you understand that we use cookies for limited purposes. What for? Privacy Policy

X